Luca Giulio Cossa Selected Research

Malignant Mesothelioma

1/2019	ADP sensitizes ZL55 cells to the activity of cisplatin.
11/2018	Adenosine diphosphate regulates MMP2 and MMP9 activity in malignant mesothelioma cells.
1/2016	In Vitro and In Vivo Antitumor Activity of [Pt(O,O'-acac)(γ-acac)(DMS)] in Malignant Pleural Mesothelioma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Luca Giulio Cossa Research Topics

Disease

6	Neoplasms (Cancer) 01/2023 - 11/2014
3	Malignant Mesothelioma 01/2019 - 01/2016
2	Breast Neoplasms (Breast Cancer) 11/2014 - 01/2014
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023
1	Adenocarcinoma 01/2023
1	Pain (Aches) 01/2020
1	Glioma (Gliomas) 01/2020
1	Inflammation (Inflammations) 01/2020
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2019
1	Mesothelioma 11/2015
1	Neuroblastoma 01/2014

Drug/Important Bio-Agent (IBA)

5	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 11/2014
2	PlatinumIBA 01/2023 - 11/2014
2	Matrix Metalloproteinases (MMPs)IBA 11/2018 - 01/2014
1	Platinum Compounds (Compounds, Platinum)IBA 01/2023
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 01/2023
1	Messenger RNA (mRNA)IBA 01/2023
1	Organometallic CompoundsIBA 01/2023
1	Phosphotransferases (Kinase)IBA 01/2023
1	Extracellular Matrix ProteinsIBA 01/2020
1	ProstaglandinsIBA 01/2020
1	BradykininIBA 01/2020
1	bcl-2-Associated X Protein (bcl 2 Associated X Protein)IBA 01/2019
1	EnzymesIBA 01/2019
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2019
1	CaspasesIBA 01/2019
1	Adenosine Diphosphate (ADP)IBA 11/2018
1	Protein Isoforms (Isoforms)IBA 11/2015
1	dimethyl sulfideIBA 11/2014
1	acetyl acetonate (acetylacetonate)IBA 11/2014
1	Metalloproteases (Metalloproteinases)IBA 01/2014
1	platinum(II) 2,4-pentanedionateIBA 01/2014

Therapy/Procedure

3	Therapeutics 01/2023 - 11/2015
1	Drug Therapy (Chemotherapy) 01/2016